ABL Bio (XKRX:298380) Price-to-Tangible-Book : 18.71 (As of May. 24, 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Price-to-Tangible-Book?

As of today (2024-05-24), ABL Bio's share price is ₩23950.00. ABL Bio's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ₩1,280.33. Hence, ABL Bio's Price to Tangible Book Ratio of today is 18.71.

The historical rank and industry rank for ABL Bio's Price-to-Tangible-Book or its related term are showing as below:

XKRX:298380' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.37 Med: 12.8 Max: 24.52
Current: 18.71

During the past 8 years, ABL Bio's highest Price to Tangible Book Ratio was 24.52. The lowest was 5.37. And the median was 12.80.

XKRX:298380's Price-to-Tangible-Book is ranked worse than
94.93% of 1223 companies
in the Biotechnology industry
Industry Median: 2.78 vs XKRX:298380: 18.71

A closely related ratio is called PB Ratio. As of today, ABL Bio's share price is ₩23950.00. ABL Bio's Book Value per Sharefor the quarter that ended in Mar. 2024 was ₩1,332.31. Hence, ABL Bio's P/B Ratio of today is 17.98.

ABL Bio Price-to-Tangible-Book Historical Data

The historical data trend for ABL Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Price-to-Tangible-Book Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

8.46

16.35

19.50

16.43

16.47

ABL Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															10.91	10.94	10.92	16.47	21.17

Competitive Comparison of ABL Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, ABL Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABL Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABL Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where ABL Bio's Price-to-Tangible-Book falls into.

ABL Bio Price-to-Tangible-Book Calculation

ABL Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	23950.00	/	1280.328
	=	18.71

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

ABL Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of ABL Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio (XKRX:298380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines